Advertisement

Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology

  • Jacob L. Roberts
  • Fady Ghali
  • Lejla Aganovic
  • Seth Bechis
  • Kelly Healy
  • Gerant Rivera-Sanfeliz
  • Riccardo Autorino
  • Ithaar DerweeshEmail author
Special Section: Urothelial Disease

Abstract

Upper tract urothelial carcinoma (UTUC) is a common and lethal malignancy. Patients diagnosed with this illness often face invasive workups, morbid therapies, and prolonged post-operative surveillance. UTUC represents approximately 5–10% of urothelial malignancies in the United States and affect 4600–7800 new patients annually. Various environmental exposures as well as smoking have been implicated in the development of UTUC. The diagnosis and workup of UTUC relies on heavily on imaging studies, a close working relationship between Urologists and Radiologists, and invasive procedures such as ureteroscopy. Treatments range from renal-sparing endoscopic surgery to radical extirpative surgery depending on the specific clinical situation. Follow-up is crucial as UTUC has a high recurrence rate. Here we review the epidemiology, diagnosis, management strategies, and follow-up of UTUC from an interdisciplinary perspective.

Keywords

Urothelial carcinoma Upper tract urothelial carcinoma Radical nephroureterectomy Ureteral neoplasm 

Notes

References

  1. 1.
    Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.
  2. 2.
    Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 67:7–30.  https://doi.org/10.3322/caac.21387 CrossRefGoogle Scholar
  3. 3.
    Kim DK, Lee JY, Kim JW, Hah YS, Cho KS (2019) Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 135:59–65.  https://doi.org/10.1016/j.critrevonc.2019.01.019 CrossRefPubMedGoogle Scholar
  4. 4.
    Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG (2009) Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224–1233.  https://doi.org/10.1002/cncr.24135 CrossRefPubMedGoogle Scholar
  5. 5.
    Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI (2017) Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol 35:367–378.  https://doi.org/10.1007/s00345-016-1885-4 CrossRefPubMedGoogle Scholar
  6. 6.
    Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF (2018) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. European Urology 73:111–122.  https://doi.org/10.1016/j.eururo.2017.07.036 CrossRefPubMedGoogle Scholar
  7. 7.
    Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164:1523–1525CrossRefGoogle Scholar
  8. 8.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.  https://doi.org/10.3322/caac.21492 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V, Upper-Tract Urothelial Carcinoma Collaborative Group (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716–723.  https://doi.org/10.1016/j.urolonc.2009.11.007 CrossRefGoogle Scholar
  10. 10.
    Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. International Journal of Urology 24:730–734.  https://doi.org/10.1111/iju.13376 CrossRefPubMedGoogle Scholar
  11. 11.
    Cosentino M, Palou J, Gaya JM, Breda A, Rodriguez-Faba O, Villavicencio-Mavrich H (2013) Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 31:141–145.  https://doi.org/10.1007/s00345-012-0877-2 CrossRefPubMedGoogle Scholar
  12. 12.
    Holmäng S, Johansson SL (2004) Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome. Cancer 101:741–747.  https://doi.org/10.1002/cncr.20395 CrossRefPubMedGoogle Scholar
  13. 13.
    Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF (2014) Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 65:742–754.  https://doi.org/10.1016/j.eururo.2013.06.010 CrossRefPubMedGoogle Scholar
  14. 14.
    Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU International 104:1436–1440.  https://doi.org/10.1111/j.1464-410x.2009.08838.x CrossRefPubMedGoogle Scholar
  15. 15.
    Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598–604.  https://doi.org/10.1002/ijc.20157 CrossRefPubMedGoogle Scholar
  16. 16.
    McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, Fraumeni JF (1992) Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 52:254–257PubMedGoogle Scholar
  17. 17.
    Shinka T, Miyai M, Sawada Y, Inagaki T, Okawa T (1995) Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol 2:243–248CrossRefGoogle Scholar
  18. 18.
    Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 104:12129–12134.  https://doi.org/10.1073/pnas.0701248104 CrossRefPubMedGoogle Scholar
  19. 19.
    Chen C-H, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu X-R, Pu Y-S, Grollman AP (2012) Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 109:8241–8246.  https://doi.org/10.1073/pnas.1119920109 CrossRefPubMedGoogle Scholar
  20. 20.
    Browne BM, Stensland KD, Moynihan MJ, Canes D (2018) An Analysis of Staging and Treatment Trends for Upper Tract Urothelial Carcinoma in the National Cancer Database. Clin Genitourin Cancer 16:e743–e750.  https://doi.org/10.1016/j.clgc.2018.01.015 CrossRefPubMedGoogle Scholar
  21. 21.
    Inman BA, Tran V-T, Fradet Y, Lacombe L (2009) Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer 115:2853–2862.  https://doi.org/10.1002/cncr.24339 CrossRefPubMedGoogle Scholar
  22. 22.
    Cowan NC (2012) CT urography for hematuria. Nat Rev Urol 9:218–226.  https://doi.org/10.1038/nrurol.2012.32 CrossRefPubMedGoogle Scholar
  23. 23.
    Jinzaki M, Kikuchi E, Akita H, Sugiura H, Shinmoto H, Oya M (2016) Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. International Journal of Urology 23:284–298.  https://doi.org/10.1111/iju.13032 CrossRefPubMedGoogle Scholar
  24. 24.
    CT Urography Working Group of the European Society of Urogenital Radiology (ESUR), Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, Nolte-Ernsting CCA, Takahashi S, Cohan RH (2008) CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol 18:4–17.  https://doi.org/10.1007/s00330-007-0792-x CrossRefGoogle Scholar
  25. 25.
    Takahashi Naoki, Glockner James F., Hartman Robert P., King Bernard F., Leibovich Bradley C., Stanley David W., Fitz-Gibbon Patrick D., Kawashima Akira (2010) Gadolinium Enhanced Magnetic Resonance Urography for Upper Urinary Tract Malignancy. Journal of Urology 183:1330–1336.  https://doi.org/10.1016/j.juro.2009.12.031 CrossRefGoogle Scholar
  26. 26.
    Sudah M, Masarwah A, Kainulainen S, Pitkänen M, Matikka H, Dabravolskaite V, Aaltomaa S, Vanninen R (2016) Comprehensive MR Urography Protocol: Equally Good Diagnostic Performance and Enhanced Visibility of the Upper Urinary Tract Compared to Triple-Phase CT Urography. PLoS One 11.  https://doi.org/10.1371/journal.pone.0158673 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Drudi FM, Candio GD, Leo ND, Malpassini F, Gnecchi M, Cantisani V, Iori F, Liberatore M (2013) Contrast-Enhanced Ultrasonography in the Diagnosis of Upper Urinary Tract Urothelial Cell Carcinoma: A Preliminary Study. Ultraschall in Med 34:30–37.  https://doi.org/10.1055/s-0032-1325548 CrossRefGoogle Scholar
  28. 28.
    Rojas CP, Castle SM, Llanos CA, Cortes JAS, Bird V, Rodriguez S, Reis IM, Zhao W, Gomez-Fernandez C, Leveillee RJ, Jorda M (2013) Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations 31:1696–1700.  https://doi.org/10.1016/j.urolonc.2012.05.010 CrossRefPubMedGoogle Scholar
  29. 29.
    Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU International 110:614–628.  https://doi.org/10.1111/j.1464-410x.2012.11068.x CrossRefPubMedGoogle Scholar
  30. 30.
    Oitchayomi A, Doerfler A, Le Gal S, Chawhan C, Tillou X (2016) Flexible and rigid ureteroscopy in outpatient surgery. BMC Urol 16.  https://doi.org/10.1186/s12894-016-0124-z CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Tanimoto R, Cleary RC, Bagley DH, Hubosky SG (2016) Ureteral Avulsion Associated with Ureteroscopy: Insights from the MAUDE Database. J Endourol 30:257–261.  https://doi.org/10.1089/end.2015.0242 CrossRefPubMedGoogle Scholar
  32. 32.
    Pan S, Smith AD, Motamedinia P (2017) Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer. Journal of Endourology 31:238–245.  https://doi.org/10.1089/end.2016.0475 CrossRefPubMedGoogle Scholar
  33. 33.
    Petros FG, Li R, Matin SF (2018) Endoscopic Approaches to Upper Tract Urothelial Carcinoma. Urologic Clinics of North America 45:267–286.  https://doi.org/10.1016/j.ucl.2017.12.009 CrossRefPubMedGoogle Scholar
  34. 34.
    Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High Rate of Pathologic Upgrading at Nephroureterectomy for Upper Tract Urothelial Carcinoma. Urology 79:615–619.  https://doi.org/10.1016/j.urology.2011.11.049 CrossRefPubMedGoogle Scholar
  35. 35.
    Liu P, Su X, Xiong G-Y, Li X-S, Zhou L-Q (2016) Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy. Int Braz J Urol 42:1129–1135.  https://doi.org/10.1590/s1677-5538.ibju.2015.0366 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Lee H-Y, Yeh H-C, Wu W-J, He J-S, Huang C-N, Ke H-L, Li W-M, Li C-F, Li C-C (2018) The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence. World J Surg Oncol 16.  https://doi.org/10.1186/s12957-018-1411-9 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha EK, Yee A, Friedman FM, Sjoberg DD, Ehdaie B, Coleman J (2016) Impact of Ureteroscopy Prior to Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes. Urology 94:148–153.  https://doi.org/10.1016/j.urology.2016.05.039 CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Huang SY, Ahrar K, Gupta S, Wallace MJ, Ensor JE, Krishnamurthy S, Matin SF (2015) Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma: Safety and diagnostic accuracy of percutaneous biopsy in UTUC. BJU Int 115:625–632.  https://doi.org/10.1111/bju.12824 CrossRefPubMedGoogle Scholar
  39. 39.
    Lohela P, Apaja-Sarkkinen M. Needle tract seeding after use of a fine needle to biopsy a renal tumour. Br Med J 1986; 292: 174CrossRefGoogle Scholar
  40. 40.
    Cutress Mark L., Stewart Grant D., Tudor Edward C.G., Egong Eric A., Wells-Cole Simon, Phipps Simon, Thomas Ben G., Riddick Antony C.P., McNeill S. Alan, Tolley David A. (2013) Endoscopic Versus Laparoscopic Management of Noninvasive Upper Tract Urothelial Carcinoma: 20-Year Single Center Experience. Journal of Urology 189:2054–2061.  https://doi.org/10.1016/j.juro.2012.12.006 CrossRefPubMedGoogle Scholar
  41. 41.
    Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Cowan NC, Kaasinen E, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M (2016) Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. European Urology 70:1052–1068.  https://doi.org/10.1016/j.eururo.2016.07.014 CrossRefPubMedGoogle Scholar
  42. 42.
    Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma. Cancer 98:55–60.  https://doi.org/10.1002/cncr.11446 CrossRefPubMedGoogle Scholar
  43. 43.
    Leow, J. J., Chong, K. T., Chang, S. L. & Bellmunt, J. Upper tract urothelial carcinoma: a different disease entity in terms of management. ESMO Open1, e000126 (2016).CrossRefGoogle Scholar
  44. 44.
    Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu J-N, Montorsi F, Traxer O (2016) Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34:1201–1206.  https://doi.org/10.1007/s00345-015-1753-7 CrossRefPubMedGoogle Scholar
  45. 45.
    De Groote R, Decaestecker K, Larcher A, Buelens S, De Bleser E, D’Hondt F, Schatteman P, Lumen N, Montorsi F, Mottrie A, De Naeyer G, De Naeyer G, Larcher A, Sopena JMG, Pini G, Grivas N, Lantz AW, Everaerts WLM, Goonewardene S, Ploumidis A, the YAU Robotic and Urothelial Group (2019) Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions. J Robotic Surg.  https://doi.org/10.1007/s11701-019-00965-8
  46. 46.
    Ni S, Tao W, Chen Q, Liu L, Jiang H, Hu H, Han R, Wang C (2012) Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol 61:1142–1153.  https://doi.org/10.1016/j.eururo.2012.02.019 CrossRefPubMedGoogle Scholar
  47. 47.
    Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, Gallucci M (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56:520–526.  https://doi.org/10.1016/j.eururo.2009.06.013 CrossRefPubMedGoogle Scholar
  48. 48.
    Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche H-M, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF (2011) Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int 108:406–412.  https://doi.org/10.1111/j.1464-410x.2010.09826.x CrossRefPubMedGoogle Scholar
  49. 49.
    Stonier T, Simson N, Lee S-M, Robertson I, Amer T, Somani BK, Rai BP, Aboumarzouk O (2017) Laparoscopic vs robotic nephroureterectomy: Is it time to re-establish the standard? Evidence from a systematic review. Arab J Urol 15:177–186.  https://doi.org/10.1016/j.aju.2017.05.002 CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M (2015) A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. European Urology 67:1122–1133.  https://doi.org/10.1016/j.eururo.2014.11.035 CrossRefPubMedGoogle Scholar
  51. 51.
    Ha Y-S, Chung J-W, Choi SH, Lee JN, Kim BS, Kim T-H, Yoo ES, Kwon TG, Byun S-S, Choi YD, Kang HW, Yun SJ, Kim W-J, Kim HT (2017) Impact of a bladder cuff excision during radical nephroureterectomy on cancer specific survival in patients with upper tract urothelial cancer in Korea: a retrospective, multi-institutional study. Minerva Urol Nefrol 69:466–474.  https://doi.org/10.23736/s0393-2249.17.02807-7 CrossRefPubMedGoogle Scholar
  52. 52.
    Evans JD, Hansen CC, Tollefson MK, Hallemeier CL (2017) Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report. Adv Radiat Oncol 3:57–61.  https://doi.org/10.1016/j.adro.2017.08.012 CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD (2010) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7:44–54.  https://doi.org/10.1038/nrclinonc.2009.188 CrossRefPubMedGoogle Scholar
  54. 54.
    Molina R, Álvarez M, Capilla J, Páez Á (2014) Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the Upper Urinary Tract After Nephroureterectomy. Korean J Urol 55:844–846.  https://doi.org/10.4111/kju.2014.55.12.844 CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF (2017) Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol 31:946–953.  https://doi.org/10.1089/end.2016.0871 CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C (2006) Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98:1181–1186.  https://doi.org/10.1111/j.1464-410x.2006.06519.x CrossRefPubMedGoogle Scholar
  57. 57.
    Novara G, De Marco V, Dalpiaz O, Gottardo F, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V (2008) Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 101:1368–1374.  https://doi.org/10.1111/j.1464-410x.2008.07438.x CrossRefPubMedGoogle Scholar
  58. 58.
    Shigeta K, Kikuchi E, Hagiwara M, Ando T, Mizuno R, Abe T, Mikami S, Miyajima A, Nakagawa K, Oya M (2017) The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma. The Journal of Urology 198:1278–1285.  https://doi.org/10.1016/j.juro.2017.06.073 CrossRefPubMedGoogle Scholar
  59. 59.
    Sevillano E, Werner L, Bossé D, Lalani A-KA, Wankowicz SAM, de Velasco G, Farina M, Lundgren K, Choueiri TK, González Del Alba A, Bellmunt J (2017) Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis. Clin Genitourin Cancer 15:e1089–e1094.  https://doi.org/10.1016/j.clgc.2017.07.012 CrossRefPubMedGoogle Scholar
  60. 60.
    Colin P, Ghoneim TP, Nison L, Seisen T, Lechevallier E, Cathelineau X, Ouzzane A, Zerbib M, Long J-A, Ruffion A, Crouzet S, Cussenot O, Audouin M, Irani J, Gardic S, Gres P, Audenet F, Roumiguié M, Valeri A, Rouprêt M (2014) Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol 32:507–512.  https://doi.org/10.1007/s00345-013-1116-1 CrossRefPubMedGoogle Scholar
  61. 61.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Ide H, Miyazaki Y, Obata J, Hoshino K, Shirotake S, Akita H, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Jinzaki M, Oya M (2014) Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location. Ann Surg Oncol 21:1038–1045.  https://doi.org/10.1245/s10434-013-3349-z CrossRefPubMedGoogle Scholar
  62. 62.
    Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M (2015) A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. European Urology 67:1122–1133.  https://doi.org/10.1016/j.eururo.2014.11.035 CrossRefPubMedGoogle Scholar
  63. 63.
    Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A (2014) Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU International 114:216–220.  https://doi.org/10.1111/bju.12341 CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Cutress Mark L., Stewart Grant D., Tudor Edward C.G., Egong Eric A., Wells-Cole Simon, Phipps Simon, Thomas Ben G., Riddick Antony C.P., McNeill S. Alan, Tolley David A. (2013) Endoscopic Versus Laparoscopic Management of Noninvasive Upper Tract Urothelial Carcinoma: 20-Year Single Center Experience. Journal of Urology 189:2054–2061.  https://doi.org/10.1016/j.juro.2012.12.006 CrossRefPubMedGoogle Scholar
  65. 65.
    Fukushima H, Saito K, Ishioka J, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Sakai Y, Arisawa C, Okuno T, Yonese J, Kamata S, Nagahama K, Noro A, Morimoto S, Tsujii T, Kitahara S, Gotoh S, Higashi Y, Kihara K (2014) Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: A propensity score-matched multicenter study. International Journal of Urology 21:1098–1104.  https://doi.org/10.1111/iju.12554 CrossRefPubMedGoogle Scholar
  66. 66.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, Taille ADL, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU International 110:1134–1141.  https://doi.org/10.1111/j.1464-410x.2012.10960.x CrossRefPubMedGoogle Scholar
  67. 67.
    Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker M-O, Gattegno B, Richard F, Cussenot O (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67:1181–1187.  https://doi.org/10.1016/j.urology.2005.12.034 CrossRefPubMedGoogle Scholar
  68. 68.
    Kim SH, Song MK, Kim JK, Hong B, Kang SH, Ku JH, Jeong BC, Seo HK (2018) Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis. Cancer Res Treat.  https://doi.org/10.4143/crt.2018.465 CrossRefGoogle Scholar
  69. 69.
    Kim TH, Hong B, Seo HK, Kang SH, Ku JH, Jeong BC (2019) The Comparison of Oncologic Outcomes between Open and Laparoscopic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Korean Multicenter Collaborative Study. Cancer Res Treat 51:240–251.  https://doi.org/10.4143/crt.2017.417 CrossRefGoogle Scholar
  70. 70.
    Lee H, Kim HJ, Lee SE, Hong SK, Byun S-S (2019) Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma. PLoS One 14.  https://doi.org/10.1371/journal.pone.0210401 CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Hu C-Y, Yang C-K, Huang C-Y, Ou Y-C, Hung S-F, Chung S-D, Pu Y-S (2015) Robot-Assisted Laparoscopic Nephroureterectomy versus Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Matched Comparison Study. Biomed Res Int 2015.  https://doi.org/10.1155/2015/918486 CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Trudeau V, Gandaglia G, Shiffmann J, Popa I, Shariat SF, Montorsi F, Perrotte P, Trinh Q-D, Karakiewicz PI, Sun M (2014) Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes. Can Urol Assoc J 8:E695–E701.  https://doi.org/10.5489/cuaj.2051 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Urology, Moores UCSD Cancer CenterUC San DiegoLa JollaUSA
  2. 2.Department of RadiologyUC San DiegoSan DiegoUSA
  3. 3.Department of UrologyColumbia UniversityNew YorkUSA
  4. 4.Division of Urology, Department of SurgeryVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations